Latest filing published 20 Dec 2019 for Monopar Therapeutics, €1.1M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -74.1%Entry US$108.70 · Close at T+365 US$28.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Karl Leo: trading record in brief
Karl Leo is a declared insider of Monopar Therapeutics, with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 18 December 2019, with 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €1.1M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 20 December 2019 with an open-market purchase (€1.1M) in Monopar Therapeutics. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Karl Leo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 156,250 shares@ US$8.0099.8% of flowCommon stockSEC:0001654954-19-014149:0Canonical exit: 17 Mar 2020 (T+90)
- 313.75 shares@ US$8.000.2% of flowCommon stockSEC:0001654954-19-014149:1Canonical exit: 17 Mar 2020 (T+90)
2 of 2 declarations
